# Anti-Inflammatory Reliever South Africa

> **NCT06429475** · PHASE3 · RECRUITING · sponsor: **University of KwaZulu** · enrollment: 1038 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide/formoterol
- **DRUG:** standard of care

## Key facts

- **NCT ID:** NCT06429475
- **Lead sponsor:** University of KwaZulu
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-06
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 1038 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06429475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06429475, "Anti-Inflammatory Reliever South Africa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06429475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*